“Tralokinumab Improves Signs and Symptoms of Moderate-to-Severe Atopic Dermatitis in Patients Aged 12 Years and Older With and Without Atopic Comorbidities”. SKIN The Journal of Cutaneous Medicine 8, no. 1 (January 16, 2024): s322. Accessed May 18, 2025. https://skin.dermsquared.com/skin/article/view/2406.